| A CFTR potentiator in patients with cystic fibrosis and the G551D mutation BW Ramsey, J Davies, NG McElvaney, E Tullis, SC Bell, P Dřevínek, ... New England Journal of Medicine 365 (18), 1663-1672, 2011 | 2398 | 2011 |
| Lumacaftor–ivacaftor in patients with cystic fibrosis homozygous for Phe508del CFTR CE Wainwright, JS Elborn, BW Ramsey, G Marigowda, X Huang, M Cipolli, ... New England Journal of Medicine 373 (3), 220-231, 2015 | 1504 | 2015 |
| Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health PA Flume, BP O'Sullivan, KA Robinson, CH Goss, PJ Mogayzel Jr, ... American journal of respiratory and critical care medicine 176 (10), 957-969, 2007 | 803 | 2007 |
| Consensus statement for inert gas washout measurement using multiple-and single-breath tests PD Robinson, P Latzin, S Verbanck, GL Hall, A Horsley, M Gappa, ... European Respiratory Journal 41 (3), 507-522, 2013 | 780 | 2013 |
| The future of cystic fibrosis care: a global perspective SC Bell, MA Mall, H Gutierrez, M Macek, S Madge, JC Davies, PR Burgel, ... The Lancet Respiratory Medicine 8 (1), 65-124, 2020 | 776 | 2020 |
| European cystic fibrosis society standards of care: best practice guidelines AR Smyth, SC Bell, S Bojcin, M Bryon, A Duff, P Flume, N Kashirskaya, ... Journal of cystic fibrosis 13, S23-S42, 2014 | 752 | 2014 |
| ECFS best practice guidelines: the 2018 revision C Castellani, AJA Duff, SC Bell, HGM Heijerman, A Munck, F Ratjen, ... Journal of cystic fibrosis 17 (2), 153-178, 2018 | 728 | 2018 |
| Impact of maternal intrapartum antibiotics, method of birth and breastfeeding on gut microbiota during the first year of life: a prospective cohort study MB Azad, T Konya, RR Persaud, DS Guttman, RS Chari, CJ Field, ... BJOG: An International Journal of Obstetrics & Gynaecology 123 (6), 983-993, 2016 | 646 | 2016 |
| Bronchoalveolar lavage in children. ERS Task Force on bronchoalveolar lavage in children. European Respiratory Society J De Blic, F Midulla, A Barbato, A Clement, I Dab, E Eber, C Green, ... European Respiratory Journal 15 (1), 217-231, 2000 | 572 | 2000 |
| Exhaled nitric oxide in pulmonary diseases: a comprehensive review PJ Barnes, RA Dweik, AF Gelb, PG Gibson, SC George, H Grasemann, ... Chest 138 (3), 682-692, 2010 | 495 | 2010 |
| Directed differentiation of human pluripotent stem cells into mature airway epithelia expressing functional CFTR protein AP Wong, CE Bear, S Chin, P Pasceri, TO Thompson, LJ Huan, F Ratjen, ... Nature biotechnology 30 (9), 876-882, 2012 | 462 | 2012 |
| The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis R Amin, A Dupuis, SD Aaron, F Ratjen Chest 137 (1), 171-176, 2010 | 422 | 2010 |
| Measurement of exhaled nitric oxide in children, 2001: E. Baraldi and JC de Jongste on behalf of the Task Force E Baraldi, JC De Jongste, B Gaston, K Alving, PJ Barnes, H Bisgaard, ... European Respiratory Journal 20 (1), 223-237, 2002 | 404 | 2002 |
| Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial L Saiman, M Anstead, N Mayer-Hamblett, LC Lands, M Kloster, ... Jama 303 (17), 1707-1715, 2010 | 389 | 2010 |
| Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial F Ratjen, A Munck, P Kho, G Angyalosi Thorax 65 (4), 286-291, 2010 | 365 | 2010 |
| Cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax PA Flume, PJ Mogayzel Jr, KA Robinson, RL Rosenblatt, L Quittell, ... American journal of respiratory and critical care medicine 182 (3), 298-306, 2010 | 323 | 2010 |
| Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia ME Faughnan, JJ Mager, SW Hetts, VA Palda, K Lang-Robertson, ... Annals of internal medicine 173 (12), 989-1001, 2020 | 319 | 2020 |
| Flexible endoscopy of paediatric airways F Midulla, J De Blic, A Barbato, A Bush, E Eber, S Kotecha, E Haxby, ... European Respiratory Journal 22 (4), 698-708, 2003 | 319 | 2003 |
| Efficacy and safety of lumacaftor and ivacaftor in patients aged 6–11 years with cystic fibrosis homozygous for F508del-CFTR: a randomised, placebo-controlled phase 3 trial F Ratjen, C Hug, G Marigowda, S Tian, X Huang, S Stanojevic, CE Milla, ... The lancet Respiratory medicine 5 (7), 557-567, 2017 | 318 | 2017 |
| Distinct spectrum of CFTR gene mutations in congenital absence of vas deferens T Dörk, B Dworniczak, C Aulehla-Scholz, D Wieczorek, I Böhm, ... Human genetics 100, 365-377, 1997 | 299 | 1997 |
